Insulin degludec and liraglutide and Ustekinumab Subcutaneous
Determining the interaction of Insulin degludec and liraglutide and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin Degludec and Liraglutide
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide-Ustekinumab Subcutaneous Injection
- Insulin degludec and liraglutide-Ustell
- Insulin degludec and liraglutide-UTA
- Insulin degludec and liraglutide-UTA Capsules
- Insulin degludec and liraglutide-UTAC tablets
- Insulin degludec and liraglutide-UTI Relief
- Ustekinumab Subcutaneous-Insulin degludec and liraglutide Subcutaneous
- Ustekinumab Subcutaneous-Insulin degludec Subcutaneous
- Ustekinumab Subcutaneous-Insulin detemir
- Ustekinumab Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ustekinumab Subcutaneous-Insulin Detemir (Vials)
- Ustekinumab Subcutaneous-Insulin detemir Subcutaneous